New findings on the effects of Covid-19 on the colon: Although SARS-CoV-2 infections mainly attack the lungs, in many cases they can also damage other organs, such as the colon: around 60% of patients experienced digestive tract impacts. Researchers at MedUni Vienna have analysed the manifestations of Covid-19 in the lungs and colon and pinpointed […]
A test to help patients manage long COVID at home has been developed. The adapted Autonomic Profile (aAP) test can be done by anyone with symptoms of autonomic dysfunction in conditions such as long COVID, chronic fatigue syndrome, fibromyalgia, and diabetes 1 and 2, where people experience dizziness or blackouts. The team behind the test […]
Read More… from Test to help patients manage long COVID at home
New study to find COVID-fighting properties in existing medications: Nearly 50 existing prescription medications already used by Australians will be tested by new research in the fight against COVID’s mutant variants. The new research, led by Associate Professor Anthony Kicic from the Curtin School of Population Health and the Wal-yan Respiratory Research Centre at Telethon […]
First real-world, peer reviewed study gives detailed new insights into when people with COVID-19 are infectious: Average duration of infectiousness in the study participants was five days Only one in five participants were infectious before COVID-19 symptoms began Two-thirds of cases were still infectious five days after their symptoms began, and one-quarter were still infectious […]
Read More… from Insights into when COVID-19 patients ARE infectious
COVID-19, rather than the threat of climate change, has spurred Australians to become more sustainable, according to research from The University of Queensland. A study led by Dr Franzisca Weder from UQ’s School of Communication and Arts found sustainable behaviours were becoming the ‘new normal’. “During lockdowns at the start of the COVID-19 pandemic we […]
First bivalent COVID-19 booster vaccine approved by UK medicines regulator: The adapted COVID-19 vaccine made by Moderna targets two different coronavirus variants – the original virus from 2020 and the Omicron variant. An updated version of the COVID-19 vaccine made by Moderna that targets two coronavirus variants (known as a “bivalent” vaccine) has today been […]
Read More… from UK first country to approve bivalent vaccine
University of Queensland-led research has found the lining of children’s noses is better at inhibiting SARS-CoV-2 infections than adult noses. Dr Kirsty Short from UQ’s School of Chemistry and Molecular Biosciences said it might be one reason why children’s immune responses have so far proven more effective at avoiding and fighting COVID-19. “Children have a […]
A needle-free vaccine patch could better fight COVID-19 variants, such as Omicron and Delta, than a traditional needle vaccine according to a University of Queensland study in mice. The research, conducted in partnership with Brisbane biotechnology company Vaxxas, tested the Hexapro SARS-CoV-2 spike vaccine using the Vaxxas high-density microarray patch (HD-MAP) technology, and the results […]
Read More… from COVID vaccine patch fights variants better then needles
Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, six months after second doses, study finds. Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven million adults. Reassuringly, the […]
Read More… from Protection still high six months after second dose
A first-of-its-kind sprayable coating that can prevent the surface spread of infection from bacteria and viruses – including COVID-19 – over a sustained period has been developed by a team of Australian researchers. Described in the journal Advanced Science, the spray works two ways: to repel viruses and bacteria through an air-filled barrier, and killing […]
Read More… from World-first spray coating shields surfaces from viruses and bacteria